BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17499950)

  • 1. Finnish guidelines for workplace drug testing.
    Lillsunde P; Haavanlammi K; Partinen R; Mukala K; Lamberg M
    Forensic Sci Int; 2008 Jan; 174(2-3):99-102. PubMed ID: 17499950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Finnish legislation on workplace drug testing.
    Lamberg ME; Kangasperko R; Partinen R; Lillsunde P; Mukala K; Haavanlammi K
    Forensic Sci Int; 2008 Jan; 174(2-3):95-8. PubMed ID: 17498899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of occupational health services in workplace drug testing.
    Lillsunde P; Mukala K; Partinen R; Lamberg M
    Forensic Sci Int; 2008 Jan; 174(2-3):103-6. PubMed ID: 17467212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-free workplace programmes: New Zealand perspective.
    Nolan S
    Forensic Sci Int; 2008 Jan; 174(2-3):125-32. PubMed ID: 17467938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers].
    Magnavita N; Bergamaschi A; Chiarotti M; Colombi A; Deidda B; De Lorenzo G; Goggiamani A; Magnavita G; Ricciardi W; Sacco A; Spagnolo AG; Bevilacqua L; Brunati MM; Campanile T; Cappai M; Cicerone M; Ciprani F; Di Giannantonio M; Di Martino G; Fenudi L; Garbarino S; Lopez A; Mammi F; Orsini D; Ranalletta D; Simonazzi S; Stanzani C
    Med Lav; 2008; 99 Suppl 2():3-58. PubMed ID: 19248471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European guidelines for workplace drug testing in urine.
    Taskinen S; Beck O; Bosch T; Brcak M; Carmichael D; Fucci N; George C; Piper M; Salomone A; Schielen W; Steinmeyer S; Weinmann W
    Drug Test Anal; 2017 Jun; 9(6):853-865. PubMed ID: 28267298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European guidelines for workplace drug testing in oral fluid.
    Brcak M; Beck O; Bosch T; Carmichael D; Fucci N; George C; Piper M; Salomone A; Schielen W; Steinmeyer S; Taskinen S; Weinmann W
    Drug Test Anal; 2018 Mar; 10(3):402-415. PubMed ID: 28657673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for European workplace drug testing in oral fluid.
    Cooper G; Moore C; George C; Pichini S;
    Drug Test Anal; 2011 May; 3(5):269-76. PubMed ID: 21538943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European guidelines for workplace drug and alcohol testing in hair.
    Salomone A; Tsanaclis L; Agius R; Kintz P; Baumgartner MR
    Drug Test Anal; 2016 Oct; 8(10):996-1004. PubMed ID: 27402378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current practice and experience in drug and alcohol testing in the workplace.
    Zwerling C
    Bull Narc; 1993; 45(2):155-96. PubMed ID: 7920540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do we have the training? The ethics of workplace drug testing and the GP.
    Evans A; Thornett A
    Aust Fam Physician; 2003 Aug; 32(8):645-7. PubMed ID: 12973876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Types of drug-testing programmes in the workplace.
    Mørland J
    Bull Narc; 1993; 45(2):83-113. PubMed ID: 7920543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicians' attitudes toward mandatory workplace urine drug testing.
    Lemon SJ; Sienko DG; Alguire PC
    Arch Intern Med; 1992 Nov; 152(11):2238-42. PubMed ID: 1444683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR; Zaloshnja E; Spicer RS
    Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accreditation should be discussed! Need for substance abuse testing at the workplace should be increased].
    Beck O; Hjemdahl P
    Lakartidningen; 1998 Jan; 95(5):407-8. PubMed ID: 9492489
    [No Abstract]   [Full Text] [Related]  

  • 17. New technology and new initiatives in U.S. workplace testing.
    Walsh JM
    Forensic Sci Int; 2008 Jan; 174(2-3):120-4. PubMed ID: 17434275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minnesota workplace drug testing. Analysis of policy and procedures.
    Reynolds JL; McGovern PM; Kochevar L; Olson DK; Hibbs BF
    AAOHN J; 1991 Nov; 39(11):523-33. PubMed ID: 1930387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--ADAMHA. Notice.
    Fed Regist; 1990 Sep; 55(172):36317-8. PubMed ID: 10170592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current list of laboratories which meet minimum standards to engage in urine drug testing for federal agencies--HHS. Notice.
    Fed Regist; 1990 Oct; 55(190):40008-9. PubMed ID: 10107029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.